World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000646151
Reproduction Date:

Title: Bronchospasm  
Author: World Heritage Encyclopedia
Language: English
Subject: Salbutamol, Asthma, Continuous positive airway pressure, Bronchial hyperresponsiveness, Propafenone
Collection: Asthma, Bronchus Disorders
Publisher: World Heritage Encyclopedia


Classification and external resources
ICD-9-CM 519.11
DiseasesDB 1715

Bronchospasm or a bronchial spasm is a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release (degranulation) of substances from mast cells or basophils under the influence of anaphylatoxins. It causes difficulty in breathing which can be very mild to severe.

Inflamed airways and bronchoconstriction in asthma. Airways narrowed as a result of the inflammatory response cause wheezing.

Bronchospasms appear as the feature of asthma, chronic bronchitis and anaphylaxis. Bronchospasms are a possible side effect of some drugs: pilocarpine (which is used to treat illness resulting from the ingestion of deadly nightshade, as well as other things), beta blockers (used to treat hypertension), a paradoxical result of using LABA drugs (to treat COPD) and other drugs. Bronchospasms can present as a sign of giardiasis.

Bronchospasms are one of several conditions associated with cold housing.[1]

Some of the things that can cause bronchospasms are: consuming foods, taking medicines, allergic responses to insects, and fluctuating hormone levels, particularly in women.[2][3]

A few of the more common allergens are foods such as eggs, milk, peanuts, walnuts, tree and other nuts, fish, especially shellfish, soy and wheat; insect bites and stings, especially bee stings; and other medicines, especially penicillin and its derivatives.

The overactivity of the bronchioles' muscle is a result of exposure to a stimulus which under normal circumstances would cause little or no response. The resulting constriction and inflammation causes a narrowing of the airways and an increase in mucus production; this reduces the amount of oxygen that is available to the individual causing breathlessness, coughing and hypoxia.

Bronchospasms are a serious potential complication of placing a breathing tube during general anesthesia. When the airways spasm or constrict in response to the irritating stimulus of the breathing tube, it is difficult to maintain the airway and the patient can become apneic.


  • Cause 1
  • Treatment 2
    • Beta 2 agonists 2.1
    • Muscarinic Acetylcholine receptor antagonist 2.2
  • See also 3
  • References 4


Bronchospasm are caused by a number of reasons. Lower respiratory tract diseases such as Pneumonia, Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Emphysema can result in contraction of the airways. Other causes are side effects of topical decongestants such as Oxymetazoline and Phenylephrine. Both of these medications activate Alpha 1 adrenergic receptors that result in smooth muscle constriction. Non-selective Beta blockers are known to facilitate bronchospasm as well. Beta blockers bind into the β2 receptors and block the action of Epinephrine and Norepinephrine from binding to its receptors, causing shortness of breath.


Beta 2 agonists

Beta2-adrenergic agonists are recommended for bronchospasm.

Muscarinic Acetylcholine receptor antagonist

See also: Parasympathetic nervous system and Sympathetic nervous system

The neurotransmitter acetylcholine is known to decrease sympathetic response by slowing the heart rate and constricting the smooth muscle tissue. Ongoing research and successful clinical trials have shown that agents such as diphenhydramine, atropine and Ipratropium bromide (all of which act as receptor antagonists of muscarinic acetylcholine receptors) are effective for treating asthma and COPD-related symptoms .

See also


  1. ^ Marsh, Alex; Gordon, David; Heslop, Pauline; Pantazis, Christina (2000). "Housing Deprivation and Health: A Longitudinal Analysis". Housing Studies 15 (3): 411.  
  2. ^ Haggerty, Catherine L.; Ness, Roberta B.; Kelsey, Sheryl; Waterer, Grant W. (2003). "The impact of estrogen and progesterone on asthma". Annals of Allergy, Asthma & Immunology 90 (3): 284.  
  3. ^ Hatfield. "Asthma in Women". 
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.